News & Insights
Stay up-to-date on recent industry trends, our independent insights, press releases, and much more.
Unintended Consequences of MFN
A few key insights from the recent AVBCC panel presentation on ex-U.S. drug access and pricing and how it could Impact MFN in the U.S.
Diagnosis-Related Groups: Why They Failed and What Comes Next
It is time to move beyond DRGs and embrace a new framework to create more sustainable healthcare models.